Neck disc study cancelled before it began
NCT ID NCT05880823
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to collect real-world information on the safety and effectiveness of the Synergy Disc, a device used to treat degenerative disc disease in the neck. It planned to look at past and future patients who received the disc. However, the study was withdrawn before enrolling any participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Expected to start
-
Apr 2024
An estimate. Start dates often move.
- Finished
-
Apr 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The patients for this study will be recruited from the physician's practice.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 21 or above at the time of the surgery. * Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted * Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy * Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression: * herniated disc and/or osteophyte formation * Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.) * Failed a minimum of 6 weeks conservative treatment * Written informed consent given by subject. Exclusion Criteria: * Exclusion Criteria: All answers must be NO to be eligible for the study. * Moderate to advanced spondylosis * Diagnosis of osteoporosis * Active systemic infection or infection at the operative site * Pregnancy * Marked cervical instability on lateral, coronal, or flexion/extension radiographs * Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level * Severe pathology of the facet joints of the involved vertebral bodies * Previous diagnosis of osteopenia or osteomalacia * More than one immobile vertebral level between C1 and T1 from any cause * Morbid obesity * Vulnerable person (pregnant patients, emergency cases, children, prisoners and people without mental capacity)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical degenerative disc disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Neurochirurgie am Gasteig
Munich, Bavaria, 81669, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Pronged surgical approach beat standard surgery for neck pain?
- New minimally invasive spine surgery could spare patients metal implants
- New screw cage may improve neck fusion surgery outcomes
- Artificial disc holds up over 5 years in neck pain study
- New artificial disc offers hope for chronic neck pain sufferers
- New artificial disc could replace fusion for neck pain